Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (10083)	5/19/1999 7:40:00 AM
From: xomadog2	Read Replies (1) \| Respond to of 17367

Robert K.- I think your math needs checking. I indicated my thought of 10 X sales as a good yardstick compared to AMGEN,as a value model for what XOMA stock could sell for if things go well. As per my previous post if XOMA did $250 million in sales multiply the sales of $250 million times 10 =s $2.5 billion..$2.5 billion in sales divided by 50 million shares=s $50 stock price. Therefore I disagree with your conclusion that $50 in stock price per billion in sales. I would suggest $200 per share per billion dollars of sales......I think there is a big huge difference in our conclusions. I conclude with the standard K disclosures...Do your own math and dont listen to mine I could be all wrong and never be right and There may never be any drug approval here.